Tuberculosis

8.

Q&A with Eliud Wandwalo, the Global Fund’s senior disease coordinator for tuberculosis

6 Nov 2018
On challenges, ‘missing people’, and integrated TB/HIV programming

Friends: Thank you for joining us, Dr. Wandwalo. While there has been progress over the last 15 years, tuberculosis (TB) is still the world’s leading infectious disease killer. What would you say have been the greatest challenges in the fight against TB?

2.

U.N. General Assembly’s high-level meeting on TB called on leaders to reaffirm commitment to end tuberculosis by 2030

2 Oct 2018
Political declaration sets ambitious targets for investment and progress monitoring

On September 26, in New York, the U.N. General Assembly hosted a first ever high-level meeting (HLM) on tuberculosis under the key theme - “United to end tuberculosis: an urgent global response to a global epidemic”. The purpose of the meeting was to provide a platform for high-level leaders to reaffirm their commitment to accelerate efforts towards the goal of ending the TB epidemic by 2030.

7.

India to host Global Fund preparatory meeting for Replenishment

18 Sep 2018

The Global Fund announced on its website on 5 September that India will host the preparatory meeting for the Sixth Replenishment in New Delhi, on 8 February 2019.

The purpose of the preparatory meeting is “to provide Global Fund partners with key information on the impact to be achieved and the financial resources needed to end the epidemics by 2030, in line with the Sustainable Development Goals,” the Fund says.

7.

Global Fund grant to Ukraine finds treatment success for multidrug-resistant TB with two-pronged approach

21 Aug 2018
Combining social and medical support achieves better treatment outcomes

According to the WHO, Ukraine remains a country with a high TB burden, and in 2014 it became one of the five countries with the highest burdens of multidrug-resistant tuberculosis (MDR TB) in the world.

6.

Iraq poised to join Global Fund’s Middle East Response initiative

2 Apr 2018
ISIS emergency disrupted transition funding for Iraq’s TB program

 

2.

Advancing the fight against TB with the expertise of the Global Fund Advocates Network

16 May 2017
The goal is to build political momentum ahead of next year’s U.N. High-Level Meeting on TB

Working through the Global Fund Advocates Network (GFAN), tuberculosis (TB) advocates are looking to strategically advance efforts to combat the disease and take advantage of several key international meetings over the coming 15 months.

5.

More global attention for tuberculosis, including increased funding to find missing patients

16 Jan 2017
Through its catalytic investments, the Global Fund is pushing $125 million into TB case finding

Two high-profile initiatives were launched late last year, each designed to shore up the response to the global tuberculosis epidemic.

6.

Uganda continues to grapple with the challenge of expired medicines and health supplies

31 Oct 2016

Findings conducted by The Observer, a Kampala based newspaper, indicate that instances of expired medicines and health supplies in Uganda is still rampant, and that expired drugs were still on the shelves at various health facilities during a recent survey conducted by the newspaper.

1.

Three ways the Global Fund could do more for TB

28 Oct 2016
The World Health Organization says global TB cases are on the rise

In October 2015, the World Health Organization reported that the Millennium Development Goal (MDG) to halt and reverse TB incidence (MDG 6c) was achieved on a worldwide basis, in each of WHO’s six regions and in 16 of the WHO’s 22 high-burden countries. While this progress is commendable, recent evidence suggests the trend may be reversing.

3.

Global health leaders discuss emerging trends in financing for HIV, TB, and malaria

17 Oct 2016
"Detailed, optimistic, and thoughtful” discussion highlights coordination and innovation

On 6 October Friends of the Global Fight, in partnership with Malaria No More and Nothing But Nets, hosted a 90-minute panel discussion on future directions for global health financing at the Henry J.

Suscribirse a Tuberculosis